Keyphrases
Akathisia
40%
All-cause Discontinuation
10%
Antipsychotics
100%
Aripiprazole
20%
Causes of Hospitalization
10%
Clinical Efficacy
10%
Comparative Analysis
10%
Discontinuation Rate
10%
Forest Plot
10%
Haloperidol
50%
Illicit Drugs
20%
India
20%
Long-acting Injectable Formulation
10%
Long-term Adverse Effects
10%
Long-term Treatment
20%
Non-adherence
20%
Olanzapine
50%
Oral Formulation
10%
Poor Adherence
10%
Popular
10%
Potential Side Effects
10%
Practice Project
10%
PRISMA-P
10%
Psychiatric Disorders
10%
Psychiatrists
40%
Psychosis
20%
Psychosis Treatment
100%
Public Health Practice
10%
Quetiapine
30%
Rating Tools
10%
Reasons for Discontinuation
10%
Relative Efficacy
10%
RevMan
10%
Risperidone
10%
Schizophrenia
100%
Statistical Analysis
10%
Switching Antipsychotics
10%
Tailored Treatment
10%
Term Analysis
20%
Time to Discontinuation
10%
Treatment Adherence
10%
Treatment Emergent
10%
Treatment Outcome
10%
Treatment Plan
10%
Weight Gain
40%
Ziprasidone
40%
Pharmacology, Toxicology and Pharmaceutical Science
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
71%
Akathisia
57%
Antipsychotic
100%
Aripiprazole
28%
Illicit Drug
28%
Olanzapine
71%
Quetiapine
42%
Risperidone
14%
Side Effect
71%
Typical Antipsychotic
100%
Ziprasidone
57%
Neuroscience
Akathisia
66%
Antipsychotic
100%
Aripiprazole
33%
Haloperidol
83%
Olanzapine
83%
Quetiapine
50%
Risperidone
16%
Typical Antipsychotic
100%
Ziprasidone
66%